Liminatus Pharma, Inc. · NASDAQ:LIMN
Valetudo Therapeutics LLC reported 1 trade in Liminatus Pharma, Inc. shares (Form 4)
Traded Jun 24, 2026 · Filed Jul 6, 2026
On Jun 24, 2026, Valetudo Therapeutics LLC (10% owner) reported 1 trade in Liminatus Pharma, Inc. shares, leaving 1,795,803 shares. Filed Jul 6, 2026 (Form 4).
- Shares
- 4,373,603 shares
- Holding after
- 1,795,803 shares
- Trading plan
- No
- Role
- 10% owner
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 24, 2026 | Common Stock, par value $0.0001 per share | Other | 4,373,603 | 1,795,803 | Direct |
Source
Related
- Liminatus Pharma, Inc.
- Valetudo Therapeutics LLC
- Liminatus Pharma, Inc. shareholders
- Form 4 · Valetudo Therapeutics LLC · Jul 14, 2026
- Schedule 13G · Samda Biolab Co., Ltd. · Jul 22, 2026
- Schedule 13D/A · Valetudo Therapeutics LLC · Jul 14, 2026
- Schedule 13G/A · Ewon Comfortech Co., Ltd. · Jul 6, 2026
- Schedule 13G · Mitchell P. Kopin · Feb 20, 2026
- Schedule 13G · KH Feelux Co., Ltd · Jun 27, 2025